Literature DB >> 15007706

Evolutionary implication of human endogenous retrovirus HERV-H family.

Joo-Mi Yi1, Heui-Soo Kim2.   

Abstract

The human endogenous retrovirus (HERV-H) family is most abundant and widely distributed in the human genome, with about 100-1,000 full-length or deleted elements and a similar number of solitary, long-terminal repeats. The HERV-H env ORF has been characterized in humans and in the course of primate evolution, indicating the increased possibility of biological roles in humans. Using the polymerase chain reaction approach with a human monochromosomal DNA panel, 70 env fragments belonging to the HERV-H family from chromosomes 1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, X, and Y were identified and analyzed. They showed 82-99% sequence similarity to that of HERV-H (accession no. AF108843). We also identified other HERV-H env fragments in the DDBJ/EMBL/GenBank databases. The total of 120 fragments was evolutionarily analyzed. Phylogenetic analysis suggests that the HERV-H env family is divided into one major and two minor groups. The HERV-H members have been actively proliferated and evolved by intra-chromosomal spread during hominid radiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007706     DOI: 10.1007/s10038-004-0132-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  21 in total

1.  Identification and phylogeny of new human endogenous retroviral sequences belonging to the HERV-H family.

Authors:  J M Lee; J Y Choi; J S Kim; B H Hyun; H S Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2000-12-10       Impact factor: 2.205

2.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

Review 3.  Retroviruses and primate evolution.

Authors:  E D Sverdlov
Journal:  Bioessays       Date:  2000-02       Impact factor: 4.345

4.  Molecular features of the TSPY gene of gibbons and Old World monkeys.

Authors:  H S Kim; H Hirai; O Takenaka
Journal:  Chromosome Res       Date:  1996-11       Impact factor: 5.239

5.  Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

Authors:  G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  Science       Date:  1985-10-25       Impact factor: 47.728

6.  Presence of env genes in members of the RTVL-H family of human endogenous retrovirus-like elements.

Authors:  Y Hirose; M Takamatsu; F Harada
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

7.  Recent evolutionary expansion of a subfamily of RTVL-H human endogenous retrovirus-like elements.

Authors:  N L Goodchild; D A Wilkinson; D L Mager
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

8.  The full-length envelope of an HERV-H human endogenous retrovirus has immunosuppressive properties.

Authors:  Marianne Mangeney; Nathalie de Parseval; Gilles Thomas; Thierry Heidmann
Journal:  J Gen Virol       Date:  2001-10       Impact factor: 3.891

9.  Tumor cells expressing a retroviral envelope escape immune rejection in vivo.

Authors:  M Mangeney; T Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.

Authors:  G J Cianciolo; D Phipps; R Snyderman
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

View more
  3 in total

1.  HERVH-derived lncRNAs negatively regulate chromatin targeting and remodeling mediated by CHD7.

Authors:  Fu-Kai Hsieh; Fei Ji; Manashree Damle; Ruslan I Sadreyev; Robert E Kingston
Journal:  Life Sci Alliance       Date:  2021-10-18

2.  Origin and Deep Evolution of Human Endogenous Retroviruses in Pan-Primates.

Authors:  Yian Li; Guojie Zhang; Jie Cui
Journal:  Viruses       Date:  2022-06-23       Impact factor: 5.818

3.  The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy.

Authors:  Chiara Cipriani; Maria Bernanda Pitzianti; Claudia Matteucci; Elisa D'Agati; Martino Tony Miele; Valentina Rapaccini; Sandro Grelli; Paolo Curatolo; Paola Sinibaldi-Vallebona; Augusto Pasini; Emanuela Balestrieri
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.